08048036315
HERMAB 440MG Injection wholesale and global supplier from India to Australia | Phoenix Exim.


1. General Information

HERMAB 440mg Injection is an anti-cancer medicine belonging to the monoclonal antibody class. Its active ingredient, trastuzumab, specifically targets the HER2 (human epidermal growth factor receptor 2) protein, which may be present in high amounts on certain cancer cells.

It is primarily associated with the treatment of HER2-positive breast cancer and HER2-positive gastric or gastroesophageal-junction cancer. Treatment should only be started after appropriate medical evaluation and HER2 testing.

Exporter information: Phoenix Exim, Nagpur, India, supplies pharmaceutical products for international markets including the USA, UK, Australia, Singapore, Canada, South Korea and UAE, subject to applicable regulations and import requirements.

2. Product Information

  • Brand: HERMAB 440mg Injection

  • Active ingredient: Trastuzumab

  • Strength: 440 mg per vial

  • Therapeutic class: Antineoplastic / monoclonal antibody

  • Dosage form: Powder for intravenous infusion

  • Manufacturer: RPG Life Sciences Ltd.

  • Route: Intravenous (IV) infusion

  • Prescription: Required

  • Storage: Refrigerate at 2°C–8°C and do not freeze.

The 440 mg trastuzumab presentation is a lyophilized powder that is reconstituted and prepared for IV infusion by qualified healthcare professionals.

3. Uses of HERMAB 440mg Injection

HERMAB may be used as part of an oncology treatment plan for:

  • HER2-positive breast cancer

  • Early-stage HER2-positive breast cancer, in appropriate treatment settings

  • Metastatic HER2-positive breast cancer

  • Advanced or metastatic HER2-positive gastric cancer

  • HER2-positive gastroesophageal-junction adenocarcinoma

Depending on the cancer and treatment setting, trastuzumab may be administered alone or together with other anti-cancer medicines.

4. Benefits of HERMAB 440mg Injection

The potential therapeutic benefits of trastuzumab include:

  • Specifically targets HER2-positive cancer cells.

  • Blocks HER2-related signals involved in cancer-cell growth and survival.

  • Can help slow the progression of certain HER2-positive cancers.

  • May be used as part of combination cancer therapy.

  • Provides targeted biological therapy rather than conventional non-specific chemotherapy alone.

The suitability and expected benefit depend on the patient's cancer type, HER2 status, stage and overall treatment plan.

5. Side Effects of HERMAB 440mg Injection

Like other cancer medicines, trastuzumab can cause side effects. Some may be temporary, while others require urgent medical attention.

Potential adverse effects include:

  • Infusion-related reactions

  • Fever or chills

  • Nausea or vomiting

  • Headache

  • Fatigue or weakness

  • Cough

  • Diarrhea

  • Muscle, joint or back pain

  • Rash

  • Sleep disturbances

  • Infections

Important serious reactions can include heart problems, severe infusion reactions and lung toxicity.

6. Common Side Effects

Commonly reported effects may include:

  • Fever

  • Chills

  • Headache

  • Nausea

  • Vomiting

  • Diarrhea

  • Fatigue

  • Cough

  • Joint or body pain

  • Rash

  • Difficulty sleeping

  • Infusion-site or infusion-related reactions

The severity and frequency can vary depending on the patient's condition and other medicines used during cancer treatment.

7. How to Use HERMAB 440mg Injection

HERMAB should not be self-administered. It is prepared and administered by a qualified healthcare professional through IV infusion.

The dosage and treatment schedule are individualized according to the indication, body weight, treatment regimen and medical condition. Trastuzumab regimens can include a loading dose followed by maintenance doses, but the exact regimen must be determined by the treating oncologist.

During administration, patients are monitored for infusion-related reactions and other complications.

8. How HERMAB 440mg Injection Works

HERMAB contains trastuzumab, a humanized IgG1 monoclonal antibody.

Trastuzumab binds specifically to the HER2 receptor on the surface of HER2-positive cancer cells. By binding to HER2, it interferes with signaling pathways that promote cancer-cell growth and survival. It can also help the immune system recognize and attack targeted cancer cells.

9. Safety Advice

  • Use HERMAB only under the supervision of a qualified oncologist.

  • HER2 status should be appropriately established before treatment.

  • Tell your doctor about any previous heart disease or reduced heart function.

  • Heart function may need to be assessed before and during treatment.

  • Report breathing difficulty, persistent cough, chest discomfort or swelling promptly.

  • Inform your healthcare provider about previous infusion or allergic reactions.

  • Pregnancy should be discussed with the treating doctor because trastuzumab can cause fetal harm.

  • Breastfeeding should be discussed with the healthcare professional before treatment.

  • Keep the product refrigerated at 2°C–8°C and do not freeze it.

  • Do not use a damaged, improperly stored or expired vial.

  • Do not attempt to prepare or administer the injection yourself.

10. FAQs

Q1. What is HERMAB 440mg Injection?
HERMAB 440mg is a trastuzumab-containing monoclonal antibody medicine used for certain HER2-positive cancers.

Q2. What is the active ingredient in HERMAB?
The active ingredient is trastuzumab 440 mg.

Q3. What cancers can HERMAB treat?
It is used in appropriate treatment settings for HER2-positive breast cancer and certain HER2-positive gastric/gastroesophageal-junction cancers.

Q4. Can HERMAB be self-injected?
No. The IV formulation must be prepared and administered by an appropriately trained healthcare professional.

Q5. How should HERMAB 440mg be stored?
It should generally be refrigerated at 2°C–8°C and must not be frozen.

Q6. Does HERMAB cause heart-related side effects?
Trastuzumab can cause cardiac complications, including reduced heart function or heart failure in some patients. Appropriate cardiac monitoring is therefore important.

Q7. Is HERMAB a prescription medicine?
Yes. HERMAB 440mg Injection is a prescription medicine and should be used under specialist medical supervision.

11. Substitutes for HERMAB 440mg Injection

Because HERMAB contains trastuzumab, possible alternatives may include other trastuzumab products with an equivalent strength or clinically appropriate dosing presentation. Examples available in some markets include:

  • Hertraz 440mg Injection

  • Herceptin 440mg

  • Herzuma 440mg

  • Other approved trastuzumab biosimilars

However, a substitute should not be selected solely by brand name. The treating oncologist or pharmacist should confirm that the alternative has the appropriate trastuzumab formulation, strength, indication and regulatory approval for the patient.

12. SEO Keywords

  • HERMAB 440mg Injection exporter from India

  • HERMAB 440mg Injection supplier from Nagpur

  • HERMAB 440mg Trastuzumab Injection exporter

  • Trastuzumab 440mg Injection supplier India

  • HERMAB 440mg wholesale pharmaceutical supplier

  • HERMAB 440mg Injection international supplier

  • HERMAB 440mg Injection for breast cancer

  • HERMAB 440mg Injection for HER2-positive cancer

  • Trastuzumab 440mg exporter to USA

  • Trastuzumab 440mg exporter to UK

  • Trastuzumab 440mg exporter to Australia

  • Trastuzumab 440mg exporter to Canada

  • Trastuzumab 440mg exporter to Singapore

  • Trastuzumab 440mg exporter to South Korea

  • Trastuzumab 440mg exporter to UAE

  • HER2 targeted therapy supplier India

  • HER2-positive breast cancer medicine exporter

  • Oncology medicine exporter from Nagpur India

  • Anti-cancer injection exporter India

  • Prescription oncology medicine supplier India

  • HERMAB 440mg pharmaceutical exporter

  • Genuine HERMAB 440mg Injection supplier

  • Trastuzumab injection wholesale supplier India

  • Pharmaceutical export company Nagpur India


Aug 22nd, 2026 12:58 PM

Keywords